Genetic mapping across autoimmune diseases reveals shared associations and mechanisms.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
13 May 2024
Historique:
received: 29 09 2021
accepted: 21 03 2024
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 13 5 2024
Statut: aheadofprint

Résumé

Autoimmune and inflammatory diseases are polygenic disorders of the immune system. Many genomic loci harbor risk alleles for several diseases, but the limited resolution of genetic mapping prevents determining whether the same allele is responsible, indicating a shared underlying mechanism. Here, using a collection of 129,058 cases and controls across 6 diseases, we show that ~40% of overlapping associations are due to the same allele. We improve fine-mapping resolution for shared alleles twofold by combining cases and controls across diseases, allowing us to identify more expression quantitative trait loci driven by the shared alleles. The patterns indicate widespread sharing of pathogenic mechanisms but not a single global autoimmune mechanism. Our approach can be applied to any set of traits and is particularly valuable as sample collections become depleted.

Identifiants

pubmed: 38741015
doi: 10.1038/s41588-024-01732-8
pii: 10.1038/s41588-024-01732-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI122220
Pays : United States

Investigateurs

Ashley H Beecham (AH)
Nikolaos A Patsopoulos (NA)
Chris Cotsapas (C)
David Booth (D)
An Goris (A)
Annette Oturai (A)
Janna Saarela (J)
Betrand Fontaine (B)
Bertrand Hemmer (B)
Martin Claes (M)
Frauke Zipp (F)
Sandra D'Alfonso (S)
Filippo Martinelli-Boneschi (F)
Bruce Taylor (B)
Hanne F Harbo (HF)
Ingrid Kockum (I)
Jan Hillert (J)
Tomas Olsson (T)
Jorge R Oksenberg (JR)
Rogier Hintzen (R)
Lisa F Barcellos (LF)
Lars Alfredsson (L)
Federica Esposito (F)
Roland Martin (R)
Jonathan L Haines (JL)
Margaret A Pericak-Vance (MA)
Adrian J Ivinson (AJ)
Graeme Stewart (G)
David Hafler (D)
Stephen L Hauser (SL)
Alastair Compston (A)
Gil McVean (G)
Philip De Jager (P)
Stephen J Sawcer (SJ)
Jakob L McCauley (JL)

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Rosenblum, M. D., Remedios, K. A. & Abbas, A. K. Mechanisms of human autoimmunity. J. Clin. Invest. 125, 2228–2233 (2015).
pubmed: 25893595 pmcid: 4518692 doi: 10.1172/JCI78088
International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).
de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017).
pubmed: 28067908 pmcid: 5289481 doi: 10.1038/ng.3760
Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
pubmed: 22955828 pmcid: 3771521 doi: 10.1126/science.1222794
Gusev, A. et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 95, 535–552 (2014).
pubmed: 25439723 pmcid: 4225595 doi: 10.1016/j.ajhg.2014.10.004
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285 doi: 10.1038/ng.3404
Hemminki, K., Li, X., Sundquist, K. & Sundquist, J. Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum. 60, 2845–2847 (2009).
pubmed: 19714648 doi: 10.1002/art.24749
Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G. & Mortensen, P. B. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 29, 1–9 (2007).
pubmed: 17582741 pmcid: 2717015 doi: 10.1016/j.jaut.2007.05.002
Kuo, C.-F. et al. Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern. Med. 175, 1518–1526 (2015).
pubmed: 26193127 doi: 10.1001/jamainternmed.2015.3528
Cotsapas, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).
pubmed: 21852963 pmcid: 3154137 doi: 10.1371/journal.pgen.1002254
Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510–518 (2016).
pubmed: 26974007 pmcid: 4848113 doi: 10.1038/ng.3528
Sirota, M., Schaub, M. A., Batzoglou, S., Robinson, W. H. & Butte, A. J. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet. 5, e1000792 (2009).
pubmed: 20041220 pmcid: 2791168 doi: 10.1371/journal.pgen.1000792
Shirai, Y. et al. Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component. Ann. Rheum. Dis. 81, 1301–1312 (2022).
pubmed: 35753705 doi: 10.1136/annrheumdis-2022-222460
Pouget, J. G. et al. Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk. Hum. Mol. Genet. 28, 3498–3513 (2019).
pubmed: 31211845 pmcid: 6891073 doi: 10.1093/hmg/ddz145
Fortune, M. D. et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat. Genet. 47, 839–846 (2015).
pubmed: 26053495 pmcid: 4754941 doi: 10.1038/ng.3330
Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).
pubmed: 23917628 doi: 10.1038/nrg3502
Burren, O. S. et al. Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases. Genome Med. 12, 106 (2020).
pubmed: 33239102 pmcid: 7687775 doi: 10.1186/s13073-020-00797-4
van de Bunt, M. et al. Evaluating the performance of fine-mapping strategies at common variant GWAS loci. PLoS Genet. 11, e1005535 (2015).
pubmed: 26406328 pmcid: 4583479 doi: 10.1371/journal.pgen.1005535
Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).
pubmed: 29292387 pmcid: 5805593 doi: 10.1038/s41588-017-0009-4
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Zhernakova, A., Withoff, S. & Wijmenga, C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat. Rev. Endocrinol. 9, 646–659 (2013).
pubmed: 23959365 doi: 10.1038/nrendo.2013.161
Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76 (2017).
pubmed: 28449694 pmcid: 5406920 doi: 10.1186/s13059-017-1207-1
Cortes, A. & Brown, M. A. Promise and pitfalls of the ImmunoChip. Arthritis Res. Ther. 13, 101 (2011).
pubmed: 21345260 pmcid: 3157635 doi: 10.1186/ar3204
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363 doi: 10.1016/j.ajhg.2010.11.011
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
pubmed: 26773131 pmcid: 4866522 doi: 10.1093/bioinformatics/btw018
Mohanan, V. et al. C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 359, 1161–1166 (2018).
pubmed: 29420262 pmcid: 6008784 doi: 10.1126/science.aan0814
Rivas, M. A. et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 43, 1066–1073 (2011).
pubmed: 21983784 pmcid: 3378381 doi: 10.1038/ng.952
Farh, K. K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337–343 (2015).
pubmed: 25363779 doi: 10.1038/nature13835
Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013).
pubmed: 23263488 doi: 10.1038/ng.2504
Chun, S. et al. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. Nat. Genet. 49, 600–605 (2017).
pubmed: 28218759 pmcid: 5374036 doi: 10.1038/ng.3795
Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167, 1398–1414.e24 (2016).
pubmed: 27863251 pmcid: 5119954 doi: 10.1016/j.cell.2016.10.026
Pappalardo, J. L. et al. Transcriptomic and clonal characterization of T cells in the human central nervous system. Sci. Immunol. 5, eabb8786 (2020).
pubmed: 32948672 pmcid: 8567322 doi: 10.1126/sciimmunol.abb8786
Kumar, S., Ambrosini, G. & Bucher, P. SNP2TFBS—a database of regulatory SNPs affecting predicted transcription factor binding site affinity. Nucleic Acids Res. 45, D139–D144 (2017).
pubmed: 27899579 doi: 10.1093/nar/gkw1064
Kundu, K. et al. Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases. Nat. Genet. 54, 251–262 (2022).
pubmed: 35288711 doi: 10.1038/s41588-022-01025-y
Foley, C. N. et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat. Commun. 12, 764 (2021).
pubmed: 33536417 pmcid: 7858636 doi: 10.1038/s41467-020-20885-8
Hernández, N. et al. The flashfm approach for fine-mapping multiple quantitative traits. Nat. Commun. 12, 6147 (2021).
pubmed: 34686674 pmcid: 8536717 doi: 10.1038/s41467-021-26364-y
Umans, B. D., Battle, A. & Gilad, Y. Where are the disease-associated eQTLs? Trends Genet. 37, 109–124 (2021).
pubmed: 32912663 doi: 10.1016/j.tig.2020.08.009
The Lenercept Multiple Sclerosis Study Group & The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457–465 (1999).
Gregory, A. P. et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488, 508–511 (2012).
pubmed: 22801493 pmcid: 4268493 doi: 10.1038/nature11307
Buniello, A. et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
pubmed: 30445434 doi: 10.1093/nar/gky1120
Paternoster, L. et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 47, 1449–1456 (2015).
pubmed: 26482879 pmcid: 4753676 doi: 10.1038/ng.3424
Ferreira, M. A. et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat. Genet. 49, 1752–1757 (2017).
pubmed: 29083406 pmcid: 5989923 doi: 10.1038/ng.3985
Han, Y. et al. Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma. Nat. Commun. 11, 1776 (2020).
pubmed: 32296059 pmcid: 7160128 doi: 10.1038/s41467-020-15649-3
Dubois, P. C. A. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295–302 (2010).
pubmed: 20190752 pmcid: 2847618 doi: 10.1038/ng.543
Lyons, P. A. et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat. Commun. 10, 5120 (2019).
pubmed: 31719529 pmcid: 6851141 doi: 10.1038/s41467-019-12515-9
Bronson, P. G. et al. Common variants at PVT1, ATG13–AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency. Nat. Genet. 48, 1425–1429 (2016).
pubmed: 27723758 pmcid: 5086090 doi: 10.1038/ng.3675
Cousminer, D. L. et al. First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes. Diabetes Care 41, 2396–2403 (2018).
pubmed: 30254083 pmcid: 6196829 doi: 10.2337/dc18-1032
Cordell, H. J. et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun. 6, 8019 (2015).
pubmed: 26394269 doi: 10.1038/ncomms9019
Ji, S.-G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269–273 (2017).
pubmed: 27992413 doi: 10.1038/ng.3745
Aterido, A. et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann. Rheum. Dis. 78, 355–364 (2019).
doi: 10.1136/annrheumdis-2018-214158
Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457–1464 (2015).
pubmed: 26502338 pmcid: 4668589 doi: 10.1038/ng.3434
López-Isac, E. et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat. Commun. 10, 4955 (2019).
pubmed: 31672989 pmcid: 6823490 doi: 10.1038/s41467-019-12760-y
Jin, Y. et al. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat. Genet. 48, 1418–1424 (2016).
pubmed: 27723757 pmcid: 5120758 doi: 10.1038/ng.3680
Feng, B.-J. et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet. 5, e1000606 (2009).
pubmed: 19680446 pmcid: 2718700 doi: 10.1371/journal.pgen.1000606
Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).
pubmed: 24390342 doi: 10.1038/nature12873
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
International HapMap 3 Consortium et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52–58 (2010).
doi: 10.1038/nature09298
Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193–1201 (2011).
pubmed: 22057235 pmcid: 3242065 doi: 10.1038/ng.998
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
pubmed: 26192919 pmcid: 4881818 doi: 10.1038/ng.3359
International Multiple Sclerosis Genetics Consortium (IMSGC) et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360 (2013).
doi: 10.1038/ng.2770
Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336–1340 (2012).
pubmed: 23143596 pmcid: 3605761 doi: 10.1038/ng.2462
Langefeld, C. D. et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 8, 16021 (2017).
pubmed: 28714469 pmcid: 5520018 doi: 10.1038/ncomms16021
Zhao, J. et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat. Genet. 49, 433–437 (2017).
pubmed: 28135245 pmcid: 5400098 doi: 10.1038/ng.3782
Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381–386 (2015).
pubmed: 25751624 pmcid: 4380767 doi: 10.1038/ng.3245
Rasmussen, A. et al. The lupus family registry and repository. Rheumatology 50, 47–59 (2011).
pubmed: 20864496 doi: 10.1093/rheumatology/keq302
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Scrucca, L., Fop, M., Murphy, T. B. & Raftery, A. E. mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R J. 8, 289–317 (2016).
pubmed: 27818791 pmcid: 5096736 doi: 10.32614/RJ-2016-021
Abraham, G. & Inouye, M. Fast principal component analysis of large-scale genome-wide data. PLoS ONE 9, e93766 (2014).
pubmed: 24718290 pmcid: 3981753 doi: 10.1371/journal.pone.0093766
Delaneau, O., Zagury, J.-F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5–6 (2013).
pubmed: 23269371 doi: 10.1038/nmeth.2307
Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
pubmed: 19543373 pmcid: 2689936 doi: 10.1371/journal.pgen.1000529
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
pubmed: 17572673 doi: 10.1038/ng2088
Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1–48 (2010).
doi: 10.18637/jss.v036.i03
GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
doi: 10.1126/science.aaz1776
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2009).
pubmed: 19910308 pmcid: 2796818 doi: 10.1093/bioinformatics/btp616
Stegle, O., Parts, L., Durbin, R. & Winn, J. A Bayesian framework to account for complex non-genetic factors in gene expression levels greatly increases power in eQTL studies. PLoS Comput. Biol. 6, e1000770 (2010).
pubmed: 20463871 pmcid: 2865505 doi: 10.1371/journal.pcbi.1000770
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
cotsapaslab / CrossDiseaseImmunochip. GitHub https://github.com/cotsapaslab/CrossDiseaseImmunochip (2021).
Lincold, M. R. matthewlincoln/xd-release: release. Zenodo https://doi.org/10.5281/zenodo.8371032 (2023).

Auteurs

Matthew R Lincoln (MR)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
Division of Neurology at the Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.

Noah Connally (N)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Pierre-Paul Axisa (PP)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Christiane Gasperi (C)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Mitja Mitrovic (M)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
Faculty of Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia.

David van Heel (D)

Blizard Institute, Queen Mary University of London, London, UK.

Cisca Wijmenga (C)

Department of Genetics at the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Sebo Withoff (S)

Department of Genetics at the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Iris H Jonkers (IH)

Department of Genetics at the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Leonid Padyukov (L)

Division of Rheumatology at the Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Stephen S Rich (SS)

Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.

Robert R Graham (RR)

Maze Therapeutics, South San Francisco, CA, USA.
Genentech, South San Francisco, CA, USA.

Patrick M Gaffney (PM)

Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Carl D Langefeld (CD)

Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Timothy J Vyse (TJ)

Department of Medical and Molecular Genetics, Kings College London, London, UK.

David A Hafler (DA)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Sung Chun (S)

Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Shamil R Sunyaev (SR)

Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Chris Cotsapas (C)

Department of Neurology, Yale School of Medicine, New Haven, CT, USA. cotsapas@gmail.com.
Department of Genetics, Yale School of Medicine, New Haven, CT, USA. cotsapas@gmail.com.
Vesalius Therapeutics, Cambridge, MA, USA. cotsapas@gmail.com.

Classifications MeSH